EARLY DETECTION
There is significant risk in waiting to screen for colorectal cancer (CRC)1
As CRC metastasizes, the 5-year survival rate decreases1,2
5-year survival rates by stage of CRC1,2*:
91%
Stages I, IIa, IIb (Localized)
73%
Stages IIc, III (Regional)
14%
Stage IV (Distant)
Timely CRC screening and early detection are essential to help reduce mortality rates and potentially save lives3
Unfortunately, more than half of eligible patients are diagnosed with regional or distant CRC1†
Many eligible patients with early-stage CRC have no symptoms, making proactive screening the only way to detect CRC4
Discover which patients are eligible for CRC screening with a noninvasive screening method
Despite the ACS lowering its initial screening age to 45 in 20185:
As of 2021, only 1 in 5 eligible patients aged 45 to 49 years reported screening for CRC6
Among eligible patients younger than 50 years, 52% were diagnosed with more advanced CRC vs 40% of patients over the age of 50 years.7‡Barriers to CRC screening
Learn about the potential barriers that may be stopping your eligible patients from screening for CRC
- Based on people diagnosed with CRC in stage I, stage IIa, or stage IIb between 2013 and 2019.1
- Based on the percentage of cases diagnosed with CRC in stage II and stage III (38%) and in stage IV (22%).1
- Data from 2004-2015 from a retrospective study of National Cancer Database.7